India’s Lupin to focus on R&D of new drugs with the expansion of Florida research hub
Tuesday, October 07, 2014
In a major development, India based pharma company, Lupin is set to create 45 jobs in technical field by expanding its research facility in Florida.
Lupin has firmly decided upon its research expansion in Florida. This new resource shall be focusing on R&D of novel drugs, giving a new dimension and support to Florida''s life-science industry.
The project is the resulth of alliance between Enterprise Florida, the Greater Fort Lauderdale Alliance, Broward County, CareerSource Florida and the Florida Department of Economic Opportunity.
This new development will involve qualified scientists for developiing inhalational products and its R&D.
“The United States is a world leader in life sciences,” Dr. Zeng said. “Lupin’s facility in Florida demonstrates a commitment to provide high quality and affordable pharmaceuticals to patients all over the world.”
Enterprise Florida President/CEO, Gray Swoope, said “Lupin’s investment in a new research and development laboratory will elevate Florida’s life sciences industry. This expansion helps position the state as the number one place for business. We are proud to see Lupin grow worldwide and find a home in Florida.”
Lupin is based in Mumbai, India and is a US owned subsidiary. It''s also ranks in the top 5 companies on the basis of prescription of drugs.
